BUSINESS

Dr Reddy's gets USFDA nod for glimepiride

Source:PTI
October 10, 2005 12:50 IST
Hyderabad based Dr Reddy's Laboratories has received approval from the US Food and Drugs Administration for multiple strengths of anti-diabetes drug glimepiride tablets.

According to information available on the USFDA website, glimeperide is available in stengths of 1 mg, 2 mg and 4 mg. The drug is a generic version of Sanofi-Aventis' Amaryl.

Dr Reddy's has also recieved tentative approval from the USFDA for anti-cholesterol drug pravastatin sodium tablets in multiple strengths. The drug is a generic version of Bristol-Myers Squibb Co's Pravachol.

Source: PTI
© Copyright 2024 PTI. All rights reserved. Republication or redistribution of PTI content, including by framing or similar means, is expressly prohibited without the prior written consent.

NEXT ARTICLE

NewsBusinessMoviesSportsCricketGet AheadDiscussionLabsMyPageVideosCompany Email